Ladenburg Thalmann Downgrades Sequenom (SQNM) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Jefferies Downgrades Sequenom (SQNM) to Hold
September 30, 2015 7:32 AM EDTJefferies downgraded Sequenom (NASDAQ: SQNM) from Buy to Hold with a price target of $1.50 (from $5.00).
Analyst Brandon Couillard commented, "Our prior Buy rating had been predicated on: 1) visibility to positive cash flow; and, 2) low valuation relative to other NIPT targets. However, after... More
William Blair Downgrades Sequenom (SQNM) to Market Perform
September 29, 2015 7:02 AM EDTWilliam Blair downgraded Sequenom (NASDAQ: SQNM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $1.92 yesterday.
... MoreSequenom (SQNM) Lowers 2nd-Half Revenue Outlook
September 25, 2015 7:06 AM EDTSequenom (NASDAQ: SQNM) is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million. This versus the consensus of $141 million.
Drivers for the updated expectations include increased competition and price... More
Sequenom (SQNM) Guides FY Revenue Below Street Views
September 25, 2015 7:05 AM EDTSequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.
The Company is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue... More
